Health News

UK regulators have approved Europe’s first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.

Read more

Filed under: Pharmacy News
Tags: HIV, medicine, Pharmacy

Related posts

• U-M scientists identify new reservoir for hidden HIV-infected cells that can serve as factory for new infections (0)
  University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. The findings, which appear online March 7 in Nature Medicine, indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for [...]
  
  
• Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show (0)
  "Treating tuberculosis (TB) and HIV infections at the same time can be a challenge for patients and their doctors, but attacking both diseases early and aggressively isn't harmful and could save the lives of those who are sickest," according to a global study led by researchers from the University of California, San Francisco (UCSF) and [...]
  
  
• Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency (0)
  Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. Read more [tags] Pharmacy [...]
  
  
• Study finds Pfizer’s pneumonia, meningitis vaccine protects against recurrent pneumonia in HIV patients (0)
  Pfizer's Prevnar 7 vaccine, which protects against pneumonia and meningitis, has been shown to reduce the risk of recurrent pneumococcal infection in patients living with HIV in Malawi, according to a study published Thursday in the New England Journal of Medicine, Reuters reports. Read more [tags] Pharmacy News [/tags]
  
  
• Scientists test new ‘therapeutic vaccine’ against HIV on volunteers (0)
  Scientists from the Antwerp Institute of Tropical Medicine, Antwerp University Hospital and Antwerp University have tested a new 'therapeutic vaccine' against HIV on volunteers. The participants were so to say vaccinated with their own cells. Read more [tags] Pharmacy News [/tags]